AR033096A1 - Acomposicion antifungal con aumentada biodisponibilidad - Google Patents

Acomposicion antifungal con aumentada biodisponibilidad

Info

Publication number
AR033096A1
AR033096A1 ARP020101198A ARP020101198A AR033096A1 AR 033096 A1 AR033096 A1 AR 033096A1 AR P020101198 A ARP020101198 A AR P020101198A AR P020101198 A ARP020101198 A AR P020101198A AR 033096 A1 AR033096 A1 AR 033096A1
Authority
AR
Argentina
Prior art keywords
accomposition
biodisponibility
antifungal
increased
pharmaceutically acceptable
Prior art date
Application number
ARP020101198A
Other languages
English (en)
Spanish (es)
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23076102&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR033096(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corp filed Critical Schering Corp
Publication of AR033096A1 publication Critical patent/AR033096A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647Triazoles; Hydrogenated triazoles
    • A01N43/6531,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dentistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
ARP020101198A 2001-04-03 2002-04-02 Acomposicion antifungal con aumentada biodisponibilidad AR033096A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28113901P 2001-04-03 2001-04-03

Publications (1)

Publication Number Publication Date
AR033096A1 true AR033096A1 (es) 2003-12-03

Family

ID=23076102

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020101198A AR033096A1 (es) 2001-04-03 2002-04-02 Acomposicion antifungal con aumentada biodisponibilidad

Country Status (18)

Country Link
US (2) US20030055067A1 (enExample)
EP (2) EP1372394A1 (enExample)
JP (2) JP4308902B2 (enExample)
KR (1) KR100607742B1 (enExample)
CN (1) CN100415234C (enExample)
AR (1) AR033096A1 (enExample)
AU (1) AU2002257104B2 (enExample)
BR (1) BR0208626A (enExample)
CA (1) CA2443089C (enExample)
HU (1) HUP0400856A3 (enExample)
MX (1) MXPA03009021A (enExample)
NO (1) NO20034419L (enExample)
NZ (1) NZ528363A (enExample)
PE (1) PE20020994A1 (enExample)
PL (1) PL212985B1 (enExample)
TW (1) TWI311464B (enExample)
WO (1) WO2002080678A1 (enExample)
ZA (1) ZA200307684B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7193084B2 (en) 2000-12-22 2007-03-20 Baxter International Inc. Polymorphic form of itraconazole
US20030072807A1 (en) * 2000-12-22 2003-04-17 Wong Joseph Chung-Tak Solid particulate antifungal compositions for pharmaceutical use
US8067032B2 (en) 2000-12-22 2011-11-29 Baxter International Inc. Method for preparing submicron particles of antineoplastic agents
US9700866B2 (en) 2000-12-22 2017-07-11 Baxter International Inc. Surfactant systems for delivery of organic compounds
WO2003026611A2 (en) 2001-09-26 2003-04-03 Baxter International Inc. Preparation of submicron sized nanoparticles via dispersion and solvent or liquid phase removal
AU2005249502A1 (en) * 2004-05-28 2005-12-15 Schering Corporation Particulate-stabilized injectable pharmaceutical compositions of posaconazole
US20060009469A1 (en) * 2004-05-28 2006-01-12 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmacutical compositions of posaconazole
US20060160823A1 (en) * 2004-05-28 2006-07-20 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmaceutical compositions of Posaconazole
US7473684B2 (en) * 2005-09-16 2009-01-06 Selamine Limited Bisphosphonate formulation
CN101495096A (zh) 2006-05-30 2009-07-29 伊兰制药国际有限公司 纳米微粒泊沙康唑制剂
MX2008015764A (es) 2006-06-14 2009-01-07 Intervet Int Bv Suspension que comprende carbamato de bencimidazol y polisorbato.
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
FR2910323A1 (fr) * 2006-12-26 2008-06-27 Virbac Sa Sa Composition liquide anhydre destinee a etre incorporee a l'eau de boisson des animaux d'elevage.
DE102008004893A1 (de) 2008-01-17 2009-07-23 Add Technologies Ltd. Trägerpellets, Verfahren zu deren Herstellung und deren Verwendung
JP2011516613A (ja) * 2008-04-15 2011-05-26 シェーリング コーポレイション 好ましくはポサコナゾールおよびhpmcasを含む固体分散物中の経口用薬学的組成物
SG10201403986UA (en) * 2008-04-15 2014-10-30 Merck Sharp & Dohme High Density Compositions Containing Posaconazole And Formulations Comprising The Same
EP2130540A1 (en) 2008-06-02 2009-12-09 Sandoz AG Pharmaceutical compositions containing a crystalline form of posaconazole
EP2141159A1 (en) 2008-07-03 2010-01-06 Sandoz AG A Crystalline form of posaconazole
WO2011003992A1 (en) 2009-07-09 2011-01-13 Sandoz Ag A crystalline form of posaconazole
CN102892762B (zh) 2010-05-19 2016-04-20 桑多斯股份公司 制备泊沙康唑中间体
BR112012029227B1 (pt) 2010-05-19 2020-01-07 Sandoz Ag Processo para a preparação de um composto quiral, composto quiral e uso de um composto
BR112012029225B1 (pt) 2010-05-19 2020-10-27 Sandoz Ag processo para a preparação de um composto quiral, composto quiral e uso de um composto quiral
MX2012013331A (es) 2010-05-19 2013-02-01 Sandoz Ag Purificacion de posaconazol y de intermediarios de posaconazol.
CA2838051C (en) 2011-06-16 2019-09-24 Sandoz Ag Process for the preparation of a chiral compound
CA2874797A1 (en) 2012-06-14 2013-12-19 Sandoz Ag Pharmaceutical composition comprising crystalline posaconazole
JP6669751B2 (ja) 2014-12-05 2020-03-18 プルモシデ リミテド 抗真菌化合物
WO2016185225A1 (en) 2015-05-21 2016-11-24 Pulmocide Limited Antifungal 4-(4-(4-(((3r,5r)-5-((1 h -1,2,4-triazol-1 -yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)- 3-methylphenyl)piperazin-1 -yl )-n -(2-h yd roxycyc lo h exyl) b e nzam i d e, or a pharmaceutically acceptable salt thereof.
CN105030668B (zh) * 2015-06-26 2018-03-27 济川药业集团有限公司 泊沙康唑口服混悬剂及其制备方法
CN106333925B (zh) * 2015-07-10 2019-06-18 上海美悦生物科技发展有限公司 一种泊沙康唑液体混悬剂及其制备方法
JP6803923B2 (ja) 2015-12-30 2020-12-23 エヌキューピー 1598,リミテッド 金属酵素阻害化合物
CN106389390A (zh) * 2016-06-30 2017-02-15 重庆华邦制药有限公司 泊沙康唑涂膜剂及其制备方法
CN107625729A (zh) * 2017-09-29 2018-01-26 重庆华邦制药有限公司 泊沙康唑口服混悬液及其制备方法
CN110507609B (zh) * 2018-05-21 2021-09-17 上海医药工业研究院 泊沙康唑口服混悬剂的制备方法
GB201917867D0 (en) 2019-12-06 2020-01-22 Pulmocide Ltd Polymorphs
US20230219936A1 (en) * 2020-05-12 2023-07-13 Cellix Bio Private Limited Process for the preparation salts of triazole compounds

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4533254A (en) 1981-04-17 1985-08-06 Biotechnology Development Corporation Apparatus for forming emulsions
US4788220A (en) * 1987-07-08 1988-11-29 American Home Products Corporation (Del.) Pediatric ibuprofen compositions
NZ234143A (en) * 1989-06-28 1991-10-25 Mcneil Ppc Inc Aqueous pharmaceutical suspension formulation for administering substantially insoluble pharmaceutical agents
US5399363A (en) 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
AU642066B2 (en) 1991-01-25 1993-10-07 Nanosystems L.L.C. X-ray contrast compositions useful in medical imaging
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5552160A (en) 1991-01-25 1996-09-03 Nanosystems L.L.C. Surface modified NSAID nanoparticles
US5661151A (en) * 1993-12-21 1997-08-26 Schering Corporation Tetrahydrofuran antifungals
HU225062B1 (en) * 1993-12-21 2006-05-29 Schering Corp Tetrahydrofuran derivatives with antifungal- effect, pharmaceutical compositions containing them and process for their preparation
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5580579A (en) * 1995-02-15 1996-12-03 Nano Systems L.L.C. Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers
WO1997018821A1 (en) * 1995-11-20 1997-05-29 Banyu Pharmaceutical Co., Ltd. Antifungal composition
US5834472A (en) * 1996-05-24 1998-11-10 Schering Corporation Antifungal composition with enhanced bioavailability
US5846971A (en) 1996-06-28 1998-12-08 Schering Corporation Oral antifungal composition
EP0995435B1 (en) * 1997-05-14 2007-04-25 Senju Pharmaceutical Co., Ltd. Aqueous suspension preparations with excellent redispersibility
JP2002516267A (ja) 1998-05-29 2002-06-04 アールティーピー・ファーマ・インコーポレーテッド 熱的に保護された微粒子組成物及びその最終蒸気滅菌
US20050048126A1 (en) * 2000-12-22 2005-03-03 Barrett Rabinow Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug

Also Published As

Publication number Publication date
NO20034419L (no) 2003-12-02
KR100607742B1 (ko) 2006-08-01
EP1372394A1 (en) 2004-01-02
PL363965A1 (en) 2004-11-29
PE20020994A1 (es) 2002-11-01
US8263600B2 (en) 2012-09-11
BR0208626A (pt) 2004-03-09
JP2004527525A (ja) 2004-09-09
HUP0400856A2 (hu) 2004-08-30
HUP0400856A3 (en) 2012-09-28
MXPA03009021A (es) 2004-02-12
NO20034419D0 (no) 2003-10-02
CN1499930A (zh) 2004-05-26
TWI311464B (en) 2009-07-01
ZA200307684B (en) 2005-03-30
KR20030087052A (ko) 2003-11-12
EP2090165A3 (en) 2012-03-28
WO2002080678A1 (en) 2002-10-17
EP2090165A2 (en) 2009-08-19
JP2008120836A (ja) 2008-05-29
CN100415234C (zh) 2008-09-03
CA2443089A1 (en) 2002-10-17
AU2002257104B2 (en) 2006-02-09
PL212985B1 (pl) 2012-12-31
JP4308902B2 (ja) 2009-08-05
US20110244004A1 (en) 2011-10-06
US20030055067A1 (en) 2003-03-20
NZ528363A (en) 2005-04-29
CA2443089C (en) 2011-11-01

Similar Documents

Publication Publication Date Title
AR033096A1 (es) Acomposicion antifungal con aumentada biodisponibilidad
AU2002310156A1 (en) 1,4-disubstituted benzo-fused cycloalkyl urea compounds
DE60019693D1 (de) Pharmazeutische zusammensetzungen, die wirkstoffabsorptionsfördernde verbindungen enthalten
MX9305277A (es) Monohidrato de 5-(2-4(1,2-benzisotiazol-3-il)-1-piperazinil)-etil-6-cloro-1,3-dihidro-2h-indol-2-1-clorhidrato.
CL2008002673A1 (es) Procedimiento se preparacion de citalopram que comprende hacer reaccionar un compuesto derivado de benzofurano con un agente eshidratante y una sulfonamida (div. sol. 2003-01).
DE69600431D1 (de) Kombination einer antimikrobiellen Verbindung (z.B. der Lipoaminosäure N,n-Octanoyl-glycin) und eines Monoalkylglycerinethers und ihre Verwendung als antimikrobieller Wirkstoff
BR9916132A (pt) Composições e utilização das mesmas
ES2095884T3 (es) Agente antiviral.
DK1385515T3 (da) Spiropyrazole forbindelser
DE59509881D1 (de) Thixotrope wässrige Pflanzenschutzmittel-Suspension
ES2080586T3 (es) Composiciones detergentes.
ATE285174T1 (de) Neuartige verbindungen
ES2139071T3 (es) Agente insecticida y acaricida derivado del triazol y proceso para la produccion del mismo.
MY120864A (en) Composition for preventing creeping of a flux for soldering and use thereof.
DE60217335D1 (de) Biozid wirkendes reinigungsmittel
ATE7799T1 (de) Bleich- und reinigungsmittelzusammensetzungen.
ES2165028T3 (es) Geles de limpieza.
DE60226836D1 (de) Stabile Elektrolytlösungen enthaltend Taurolidin
ATE150036T1 (de) Ziegler-natta-katalysatorsysteme mit speziellen siliciumorganischen verbindungen
BR0012751A (pt) Benzofuranos serotonérgicos
EA200100364A1 (ru) Тиазолилциннамонитрилы и средства борьбы с вредителями
AR025189A1 (es) Tampon y proceso para su fabricacion
LT2003100A (en) S-omeprazole inclusion complex with cyclodextrins
ES2094681B1 (es) Composiciones plaguicidas
ES2193007T1 (es) Formulacion farmaceutica estable que comprende la modificacion ii de torsemida.

Legal Events

Date Code Title Description
FC Refusal